Literature DB >> 6987202

Polymyositis in dogs.

J N Kornegay, E J Gorgacz, D L Dawe, J M Bowen, N A White, E V DeBuysscher.   

Abstract

Polymyositis was diagnosed in nine dogs. Factors utilized in making the diagnosis included (1) muscle pain or weakness, (2) high concentrations of serum muscle enzymes, (3) electromyographic abnormalities, and (4) histopathologic evidence of muscle necrosis and inflammation. Clinical signs included muscle pain, weakness, stilted gait, and pyrexia. Serum muscle enzyme concentrations were high in only three dogs. There was no apparent correlation between enzyme concentrations and severity of clinical involvement or degree of muscle necrosis on biopsy. Electromyographic changes included polyphasic motor unit potentials, fibrillation potentials, and positive waves. Variable degrees of muscle regeneration, degeneration, and inflammation were seen. Prednisone (2.2 mg/kg, OD, per os) was used effectively to treat four dogs. One dog improved initially but was euthanatized later when clinical signs became more pronounced. Three other dogs developed aspiration pneumonia secondary to megaesophagus and either died or were euthanatized.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987202

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  Familial canine dermatomyositis. Initial characterization of the cutaneous and muscular lesions.

Authors:  A M Hargis; K H Haupt; G A Hegreberg; D J Prieur; M P Moore
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

Review 2.  Creatine kinase in the dog: a review.

Authors:  M Aktas; D Auguste; H P Lefebvre; P L Toutain; J P Braun
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

3.  Animal model of human disease. Dermatomyositis. Familial canine dermatomyositis.

Authors:  A M Hargis; K H Haupt; D J Prieur; M P Moore
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

4.  Vacuolar myopathy in a dog resembling human sporadic inclusion body myositis.

Authors:  Jason King; Richard A LeCouteur; Monica Aleman; D Colette Williams; Peter F Moore; Ling T Guo; Andrew P Mizisin; G Diane Shelton
Journal:  Acta Neuropathol       Date:  2009-08-29       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.